Tata India Pharma & Healthcare Fund Regular Growth
Medium
Risk
Equity
Other
+
19.92
%
19.92
%
3Y annualised
+
0.23
%
0.23
%
1D
1M
6M
1Y
3Y
All
Fund size
872
NAV:
Mar 7, 2024
25.0966
Sector
Tech
Type
Equity
Launched
Dec 2015
Min Investment
5000
Expense Ratio
2
Risk
Medium
Portfolio allocation
Top 10 Holdings
% Value
Sun Pharmaceuticals Industries Ltd
14.28
%
Lupin Ltd
10.08
%
Aurobindo Pharma Ltd
8.44
%
Cipla Ltd
7.04
%
Dr Reddy's Laboratories Ltd
5.34
%
Zydus Lifesciences Ltd
5.17
%
Divi's Laboratories Ltd
4.2
%
Apollo Hospitals Enterprise Ltd
4.12
%
Alkem Laboratories Ltd
4
%
Fortis Healthcare Ltd
4
%
Expense ratio, exit load and tax
Expense Ratio:
2
%
Inclusive of GST
Exit load
Exit load of 0.25% if redeemed within 30.0 Days, 0.0 % if redeemed after 30.0 Days.
Tax implication
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
Fund house & investment objective
Tata India Pharma & Healthcare Fund Regular Growth
More details
Investment objective
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.
Scheme Information Document
Mutual Fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance is not an indicator of future returns.
Calculate returns
One-time
Monthly SIP
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
* Returns are calculated as per lifetime average per annum returns of the fund.
Calculate returns
Monthly SIP
One-time
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
